Croda International Announces Director/PDMR Shareholding
The specialty chemicals company has disclosed changes to the shareholdings of its executive directors and other persons discharging managerial responsibilities.
The specialty chemicals company has disclosed changes to the shareholdings of its executive directors and other persons discharging managerial responsibilities.
The specialty chemicals company has appointed UBS as a joint corporate broker, working alongside Morgan Stanley.
The company secretary and a person closely associated with them have purchased additional shares in the specialty chemicals firm.
The specialty chemicals company has announced a director has increased their shareholding through a dividend reinvestment program.
The specialty chemicals company has announced that several of its senior executives have increased their shareholdings through the firm's employee share plan.
The non-executive director of the specialty chemicals company has purchased additional shares.
The specialty chemicals company reports strong Q1 2025 sales growth, with all business segments performing well. The firm is making progress on its strategic priorities, though the outlook remains cautious amid global economic uncertainty.
The specialty chemicals company has disclosed changes to shareholdings of its directors and other persons discharging managerial responsibilities.
The specialty chemicals company has disclosed a non-executive director's purchase of shares.
The specialty chemicals company has disclosed insider transactions by the Company Secretary and a person closely associated.